ICCVAM Workgroups
ICCVAM establishes ad hoc workgroups to perform specific tasks important for the development or validation of alternatives to animal testing. The workgroups are composed of representatives from agencies that use or require data from the topic of interest. Representatives of partner organizations in the International Cooperation on Alternative Test Methods may also be invited to participate in a workgroup.
ICCVAM workgroups play a key role in carrying out ICCVAM activities, including implementing the goals of the Strategic Roadmap for Establishing New Approaches to Evaluate the Safety of Chemicals and Medical Products in the United States. When a workgroup completes its charge tasks, it transitions to an expert group to facilitate continued communication and engagement in that area of interest.
During 2022-2023, ICCVAM had active workgroups focused on the following areas:
- Acute toxicity: co-chairs Donald Cronce, Ph.D. (DoD) and Grace Patlewicz, Ph.D. (EPA)
- Consideration of alternative methods: co-chairs Jessie Carder (USDA), Matthew Johnson, D.V.M., DACLAM (DoD; through March 2022), and Shannon Marko, D.V.M. (DoD)
- Ecotoxicology: co-chairs William Eckel, Ph.D. (EPA) and Natalia Garcia-Reyero Vinas, Ph.D. (DoD)
- In vitro to in vivo extrapolation: transitioned to expert group status in 2023; co-chairs Moiz Mumtaz, Ph.D. (ATSDR) and Cecilia Tan, Ph.D. (EPA)
- PFAS: co-chairs Natalia Garcia-Reyero Vinas, Ph.D. (DoD), Kelly Carstens, Ph.D. (EPA), and Shruit Kabadi, Ph.D. (FDA)
- Read across: transitioned to expert group status in 2022; chair Grace Patlewicz, Ph.D. (EPA)
- Validation: co-chairs Suzanne Fitzpatrick, Ph.D., D.A.B.T. (FDA), John Gordon, Ph.D. (CPSC), and Elijah Petersen, Ph.D. (NIST)